261 related articles for article (PubMed ID: 31703770)
1. Clinical Translation of Pluripotent Stem Cell Therapies: Challenges and Considerations.
Desgres M; Menasché P
Cell Stem Cell; 2019 Nov; 25(5):594-606. PubMed ID: 31703770
[TBL] [Abstract][Full Text] [Related]
2. An eye to the future: Researchers debate best path for stem cell-derived therapies.
Chakradhar S
Nat Med; 2016 Feb; 22(2):116-9. PubMed ID: 26845400
[No Abstract] [Full Text] [Related]
3. Immunogenicity of induced pluripotent stem cells.
Okita K; Nagata N; Yamanaka S
Circ Res; 2011 Sep; 109(7):720-1. PubMed ID: 21921270
[No Abstract] [Full Text] [Related]
4. Good practice.
Nature; 2014 Jun; 510(7504):187-8. PubMed ID: 24926498
[No Abstract] [Full Text] [Related]
5. Human embryonic and induced pluripotent stem cells in clinical trials.
Ilic D; Devito L; Miere C; Codognotto S
Br Med Bull; 2015; 116():19-27. PubMed ID: 26582538
[TBL] [Abstract][Full Text] [Related]
6. Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy.
Cooper O; Parmar M; Isacson O
Prog Brain Res; 2012; 200():265-76. PubMed ID: 23195423
[TBL] [Abstract][Full Text] [Related]
7. Pluripotent stem cell replacement approaches to treat type 1 diabetes.
Pellegrini S; Piemonti L; Sordi V
Curr Opin Pharmacol; 2018 Dec; 43():20-26. PubMed ID: 30071348
[TBL] [Abstract][Full Text] [Related]
8. Human embryonic stem cell therapies for neurodegenerative diseases.
Tomaskovic-Crook E; Crook JM
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):440-8. PubMed ID: 21495960
[TBL] [Abstract][Full Text] [Related]
9. Prospects and challenges for the use of stem cell technologies to develop novel therapies for Parkinson disease.
Chinta SJ; Andersen JK
Cell Cycle; 2011 Dec; 10(24):4179-80. PubMed ID: 22157187
[No Abstract] [Full Text] [Related]
10. [Retinal cell therapy using iPS cells].
Takahashi M
Rinsho Shinkeigaku; 2013; 53(11):1016. PubMed ID: 24291864
[No Abstract] [Full Text] [Related]
11. Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells.
Pearl JI; Lee AS; Leveson-Gower DB; Sun N; Ghosh Z; Lan F; Ransohoff J; Negrin RS; Davis MM; Wu JC
Cell Stem Cell; 2011 Mar; 8(3):309-17. PubMed ID: 21362570
[TBL] [Abstract][Full Text] [Related]
12. "Mouse Clone Model" for evaluating the immunogenicity and tumorigenicity of pluripotent stem cells.
Zhang G; Zhang Y
Stem Cell Res Ther; 2015 Dec; 6():255. PubMed ID: 26687081
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and allogenicity: a challenge of stem cell therapy.
Charron D; Suberbielle-Boissel C; Al-Daccak R
J Cardiovasc Transl Res; 2009 Mar; 2(1):130-8. PubMed ID: 20559977
[TBL] [Abstract][Full Text] [Related]
14. The use of pluripotent stem cell for personalized cell therapies against neurological disorders.
Ha HY; Jang SH; Jung JW
J Biomed Biotechnol; 2011; 2011():520816. PubMed ID: 22203784
[TBL] [Abstract][Full Text] [Related]
15. Tolerance induction to human stem cell transplants with extension to their differentiated progeny.
Lui KO; Howie D; Ng SW; Liu S; Chien KR; Waldmann H
Nat Commun; 2014 Dec; 5():5629. PubMed ID: 25434740
[TBL] [Abstract][Full Text] [Related]
16. Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells?
Ronaghi M; Erceg S; Moreno-Manzano V; Stojkovic M
Stem Cells; 2010 Jan; 28(1):93-9. PubMed ID: 19904738
[TBL] [Abstract][Full Text] [Related]
17. Stem Cells Therapy for Spinal Cord Injury.
Gazdic M; Volarevic V; Harrell CR; Fellabaum C; Jovicic N; Arsenijevic N; Stojkovic M
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29601528
[TBL] [Abstract][Full Text] [Related]
18. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
Chen W; Huang Q; Ma S; Li M
ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
[TBL] [Abstract][Full Text] [Related]
19. Concise review: cell therapy and tissue engineering for cardiovascular disease.
Haraguchi Y; Shimizu T; Yamato M; Okano T
Stem Cells Transl Med; 2012 Feb; 1(2):136-41. PubMed ID: 23197760
[TBL] [Abstract][Full Text] [Related]
20. Perspectives and future directions of human pluripotent stem cell-based therapies: lessons from Geron's clinical trial for spinal cord injury.
Lukovic D; Stojkovic M; Moreno-Manzano V; Bhattacharya SS; Erceg S
Stem Cells Dev; 2014 Jan; 23(1):1-4. PubMed ID: 23980630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
